Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | CTSK | P43235 | 3/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL187395 | 0.79 | ELANE (0.36) | ELANEDGAT1HDAC6HDAC1HDAC2 | |
| SCHEMBL27835583 | 0.77 | TDP1 (0.38) | TDP1DGAT1HDAC6HDAC1HDAC2 | |
| SCHEMBL5539990 | 0.77 | HDAC6 (0.38) | ELANEDGAT1HDAC6HDAC1HDAC2 | |
| SCHEMBL1128473 | 0.77 | — | — | |
| SCHEMBL17300712 | 0.77 | ALDH1A1 (0.33) | TDP1 | |
| SCHEMBL29121 | 0.76 | DGAT1 (0.46) | TDP1ELANEDGAT1HDAC6HDAC1 | |
| SCHEMBL12604849 | 0.75 | ELANE (0.34) | ELANEDGAT1HDAC6HDAC1HDAC2 | |
| SCHEMBL2639330 | 0.75 | ELANE (0.34) | ELANEDGAT1HDAC6HDAC1HDAC2 | |
| SCHEMBL4494016 | 0.75 | TDP1 (0.36) | TDP1ELANEDGAT1HDAC6HDAC1 | |
| Fluoride SCHEMBL2692246 | 0.74 | DGAT1 (0.43) | TDP1ELANEDGAT1HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119996392-A | Method, system, equipment and storage medium for efficiently decoding GTS (gateway transport stream) water level message data | 国家海洋环境预报中心 | 2025-05-13 | — | — | CN | claimed |
| CN-119311333-B | Method for realizing MaaS platform operation ecologization based on large model evaluation technology | 浩鲸云计算科技股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119311333-A | Method for realizing MaaS platform operation ecologization based on large model evaluation technology | 浩鲸云计算科技股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-113379677-B | Static stacking CO60 radioactive source early warning method based on artificial intelligence | 南京新频点电子科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-112149722-B | Image automatic labeling method based on unsupervised domain adaptation | 南京大学 | 2024-01-16 | — | — | CN | claimed |
| CN-115968086-A | Classroom energy-saving lamp control system based on image recognition and control method thereof | 西安电子科技大学 | 2023-04-14 | — | — | CN | claimed |
| CN-114044772-A | Epipiprazole synthesis method and intermediate thereof | 浙江国邦药业有限公司 | 2022-02-15 | — | — | CN | claimed |
| US-20260147459-A1 | SYSTEMS AND METHODS FOR DYNAMIC USER INTERFACE INTERACTIONS | Signet Health Corporation (US) | 2026-05-28 | — | — | US | disclosed |
| US-12579594-B1 | Systems and methods for dynamically updating data for course generation | BH Operations, LLC (US) | 2026-03-17 | — | — | US | disclosed |
| US-12561392-B2 | Relative fuzziness for fast reduction of false positives and false negatives in computational text searches | DENNINGHOFF KARL LOUIS (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4290372-B1 | FUNCTION CALLING CONTEXT ENCODING METHOD AND APPARATUS, AND FUNCTION CALLING CONTEXT DECODING METHOD AND APPARATUS | HUAWEI TECH CO LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| US-20250371079-A1 | CLASSIFYING DOCUMENTS USING A DOMAIN-SPECIFIC NATURAL LANGUAGE PROCESSING MODEL | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-12-04 | — | — | US | disclosed |
| US-12443575-B1 | Systems and methods for validation of data entries for user interface data sets | JASE MEDICAL L.L.C. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-1505968-A1 | MULTICYCLIC COMPOUNDS FOR USE AS MELANIN CONCENTRATING HORMONE ANTAGONISTS IN THE TREATMENT OF OBESITY AND DIABETES | ELI LILLY AND COMPANY (US) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097047-A1 | MULTICYCLIC COMPOUNDS FOR USE AS MELANIN CONCENTRATING HORMONE ANTAGONISTS IN THE TREATMENT OF OBESITY AND DIABETES | ELI LILLY AND COMPANY (US) | 2003-11-27 | — | — | WO | disclosed |
| US-6201119-B1 | 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-03-13 | — | — | US | disclosed |
| CN-1193276-A | Use of oxido-squalene cyclase inhibitors for lowering cholesterol in blood | ZENECA LTD (GB) | 1998-09-16 | — | — | CN | disclosed |
| US-5371079-A | Administering to inhibit replication of HIV-1 in human cells | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-12-06 | — | — | US | disclosed |
| US-5270464-A | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-12-14 | — | — | US | disclosed |
| US-3937699-A | BACTERICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12561392-B2 | Relative fuzziness for fast reduction of false positives and false negatives in computational text searches | SET, FASTKD5, CPSF6 | TDP1 2395/4885ELANE 3799/4885DGAT1 4801/4885 |
| US-12579594-B1 | Systems and methods for dynamically updating data for course generation | STAT4, STAT1, DDX5 | TDP1 340/4885ELANE 1137/4885DGAT1 3787/4885 |
| US-20260147459-A1 | SYSTEMS AND METHODS FOR DYNAMIC USER INTERFACE INTERACTIONS | EPHA7, EPHA6, EPHA8 | TDP1 972/4885ELANE 3087/4885DGAT1 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.